COMPANY

    LEADERSHIP

    Yongho Oh

    CEO
    / President

    • - Leader of AI New Drug TF : Theragen Group ​
    • - Head of Business Development, Open Innovation R&D Center & Global business Dept., Theragen Etex
    • - ​Head of Development Dept. :  Icure and Ilsung pharma.
    • - M.S./B.S. in Pharmacy, Seoul National University​
    Hyunjin KIM

    CTO / Vice President

    • - Director of Medicinal Chemistry, CKD Pharmaceutical Co.
    • - Associate Principal Scientist, Merck & Co. (US)
    • - Staff Scientist, Celera Genomics (US)
    • - Postdoctoral Scholar, California Institute of Technology (US)
    • - Ph.D. in Chemistry, Columbia Univ. NY
    Moonhee Kim

    CBO,
    Chief Biology
    Officer

    • - Head of Biology Lab., J2H biotech.
    • - Research Professor, Ewha Women’s University
    • - Ph.D. in Pharmacy, Ewha Women’s University
    Junhee Pyo

    CDO,
    Chief Data Analytics
    Officer

    • - Data Scientist, Roche   ​
    • - Research Associate II, Tufts Medical Center​
    • - Ph.D in Biomedical Engineering, University of Ulsan College of Medicine
    Jihye Ryu

    CBSO,
    Chief Business
    Strategy Officer

    • - Team Leader of Business Development, Dong-A ST
    • - Senior scientist, Research planning, Dong-A ST
    • - Ph.D. in Pharmacology, Seoul National Univ. Collage of Medicine
    Gangse Lee

    CFO

    • - Angel Investor​
    • - Executive Director, i.sens Inc.​
    • - M.S., Animal Science and Technology, Seoul National University